Spire Wealth Management »

Enlivex Therapeutics shares owned by Spire Wealth Management

Quarter-by-quarter ownership of Enlivex Therapeutics (ENLV) shares owned by Spire Wealth Management from 13F filings

Historical chart of Spire Wealth Management investment in Enlivex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enlivex Therapeutics held by Spire Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enlivex Therapeutics by Spire Wealth Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $520 500 1.04
2025-06-30 $560 500 1.12
2024-12-31 $585 500 1.17